aTyr Pharma, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR Business Wire aTyr hits record low as lung disease drug fails in late-stage trial Reuters aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis Yahoo Finance aTyr flunks phase 3 lung disease trial, deflating stock, but still …
Read More »